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In eukaryotes, both natural and engineered fusions 
of ubiquitin to itself or other proteins are  cleaved by 
processing proteases after the last ( G ~ Y ‘ ~ )  residue of 
ubiquitin. Using the method  of sib  selection, and taking 
advantage of the fact that bacteria such as Escherichia 
coli lack ubiquitin-specific enzymes, we have cloned a 
gene, named U B P l ,  of the yeast Saccharomyces  cere- 
visiae that encodes a ubiquitin-specific processing pro- 
tease. With the exception of polyubiquitin, the UBPl 
protease cleaves at the carboxyl terminus of the ubiqui- 
tin moiety in natural and engineered fusions irrespec- 
tive of their size or the presence of an amino-terminal 
ubiquitin extension. These properties of UBPl distin- 
guish it from the previously cloned yeast protease 
YUH1, which deubiquitinates relatively short ubiqui- 
tin fusions but is virtually  inactive  with longer fusions 
such as ubiquitin-&galactosidase. The amino acid se- 
quence of the 809-residue UBPl lacks  significant sim- 
ilarities to other known proteins, including the 236- 
residue YUHl protease. Null ubpl mutants are  viable, 
and retain the ability to deubiquitinate ubiquitin-0- 
galactosidase, indicating that the family of ubiquitin- 
specific proteases in yeast is not limited to UBPl and 
YUH1. 
Ubiquitin (Ub),’ a highly conserved 76-residue protein, is 
present in eukaryotic cells either free or covalently joined to 
a great variety of proteins. The posttranslational coupling of 
ubiquitin to other proteins is catalyzed by a family of Ub- 
conjugating enzymes (also called E2 enzymes (Pickart and 
Rose, 1985)) and involves formation of an isopeptide bond 
between the carboxyl-terminal glycine residue of ubiquitin 
and the E-amino group of a lysine residue in an acceptor 
protein  (Pickart, 1988; Jentsch et al., 1990). A major function 
of ubiquitin is to mark proteins  destined for selective degra- 
dation (reviewed by Hershko, 1988; Finley et al., 1988; Cie- 
chanover and Schwartz, 1989;  Olson and Dice,  1989; Monia 
et al., 1990). Ubiquitin has also been shown to have a  chap- 
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erone  function, in that  its  transient (cotranslational) covalent 
association with specific ribosomal proteins promotes the 
assembly of ribosomal subunits (Finley et al., 1989). In vivo 
acceptors of ubiquitin include chromosomal histones  (Bonner 
et al., 1988), integral membrane proteins such as the lympho- 
cyte homing receptor and the growth hormone receptor (Sie- 
gelman et al., 1986; Leung et al., 1987), actin (Ball et al., 
1987), the intracellular neurofibrillary tangles in a variety of 
neurodegenerative diseases (Perry et al., 1987; Lowe et al., 
1988), the  plant regulatory protein phytochrome (Jabben et 
al., 1989), the short-lived MATa2 repressor of the yeast 
Saccharomyces cereuisiae (Hochstrasser et al., 1991), and cy- 
clins, a family of short-lived cell  cycle regulators (Glotzer et 
al., 1991). 
Unlike branched  Ub-protein conjugates, which are formed 
posttranslationally,  linear  Ub-protein  adducts  are formed as 
the translational products of either natural or engineered 
ubiquitin gene fusions. Thus, in S. cereuisiae for example, 
ubiquitin is generated exclusively by proteolytic processing of 
precursors in which ubiquitin is joined either to itself, as in 
the linear polyubiquitin protein UBI4, or to unrelated amino 
acid sequences, as in the hybrid proteins UBI1-UBI3 (Ozkay- 
nak et al., 1987). In growing yeast cells, ubiquitin is generated 
from the UBI1-UBI3 precursors whose “tails” are specific 
ribosomal proteins (Finley et al., 1989). The polyubiquitin 
(UBI4)  gene is dispensable in growing cells but becomes 
essential (as the main supplier of ubiquitin) during stress 
(Finley et al., 1987, 1988). The lack of genes encoding mature 
ubiquitin and  the fusion structure of ubiquitin precursors in 
yeast  are  characteristic of other eukaryotes as well (Schles- 
inger and Bond, 1987). Thus, there must exist Ub-specific 
processing proteases that produce ubiquitin, a  protein essen- 
tial for cell viability (Finley et al., 1984, 1987, 1988), by 
cleaving Gly-X peptide bonds at  the junctions between ubiqui- 
tin  and  its carboxyl-terminal extensions. A priori, these pro- 
teases may also have an isopeptidase activity, i.e. the ability 
to deubiquitinate posttranslationally formed, branched Ub- 
protein conjugates. A multiubiquitin chain is one such con- 
jugate, in which ubiquitin itself serves as  an acceptor, with 
several ubiquitin moieties attached sequentially to  the initial 
acceptor protein to form a  chain of branched Ub-Ub adducts 
(Chau et al., 1989). Formation of a multiubiquitin chain on a 
targeted  protein is required for the protein’s subsequent deg- 
radation  (Chau et al., 1989; Gregori et al., 1990). 
Ub-specific, ATP-independent proteases capable of cleav- 
ing ubiquitin from its  linear or branched conjugates have  been 
detected in all eukaryotes examined (Matsui et al., 1982;  Rose, 
1988; Mayer and Wilkinson, 1989; Jonnalagadda et al., 1989) 
but  not in bacteria  such  as Escherichia coli, which  lack eukar- 
yotic ubiquitin and Ub-specific enzymes (Finley et al., 1988). 
Recently, Miller et al. (1989) have cloned a S. cereuisiae gene, 
named YUHl ,  for a Ub-specific protease that cleaves ubiqui- 
tin from its carboxyl-terminal fusions to relatively short 
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amino acid sequences but is virtually inactive with larger 
fusions such as Ub-@-galactosidase (Ub-@gal). Wilkinson et 
al. (1989)  have also cloned a cDNA for a mammalian homolog 
of the yeast YUHl protease. 
We  now report the cloning and functional analysis of an S. 
cereuisiue gene, named UBPl, which encodes a Ub-specific 
processing protease whose amino acid sequence is dissimilar 
to those of the  YUHl protease and  other known proteins. 
The  UBPl protease cleaves at  the carboxyl terminus of the 
ubiquitin moiety in linear fusions irrespective of their size or 
the presence of an amino-terminal ubiquitin extension. We 
also show that null ubpl mutants  are viable and have prop- 
erties indicating that  the family of Ub-specific proteases in 
yeast is not limited to  UBPl  and YUH1. 
Since Ub-specific proteases cleave ubiquitin from its  car- 
boxyl-terminal extensions irrespective of the identity of the 
extension's residue abutting  the cleavage site (Bachmair et 
al., 1986; Gonda et al., 1989), UBPl  and its  functional coun- 
terparts make possible the in vivo or in vitro generation of 
proteins (including short polypeptides) bearing predetermined 
residues at their amino termini, a method with applications 
in both basic research (Baker  and Varshavsky, 1991; Bartel 
et al., 1990; Johnson et al., 1990; Townsend et al., 1988) and 
biotechnology (Lu et al., 1990; Butt et al., 1989; Sabin et al., 
1989; Ecker et al., 1989;  Yo0 et al., 1989; Mak et al., 1989). 
EXPERIMENTAL  PROCEDURES 
Strains, Media, and Genetic Techniques-E. coli strains HBlOl 
(pro leu thi lacy hsdS~20 endA  secA rpsL20 ara-14 galK2 xyl-5 mtl-1 
supE44 merBB;  Boyer and Roulland-Dussoix, 1969) and  JMlOl  (supE 
thi A(lac-proAB)/F' traA36 proA+ proB+ lacIq lacZAM15; Yanisch- 
Perron  et al., 1985) were propagated in Luria broth (LB)  and used as 
hosts for plasmids and phage M13 derivatives. The S. cereuisk 
strains used were DF5 (MATaIMATa  trpl-lltrpl-1  ura3-51/urd- 
51 hL3-A2000/his3-A2000 leu2-3,112/leu2-3,112 lys2-801/lys2-801 
gallgal; Finley et al., 1987),  BBY45 (MATa  trpl-I  urd-52 his3-A2000 
leu2-3,112 lys2-801 gal; Bartel et al., 1990), and BWGl-7a (MATa 
hL4 ura3 adel leu2; Guarente et al., 1982). Rich (YPD) and synthetic 
yeast media  were prepared according to Sherman et al. (1986). Trans- 
by the lithium acetate method (Ito  et al., 1983) and by the calcium 
formations of S. cereukiue and E. coli were carried out, respectively, 
chloride method (Ausubel et al., 1989). The DNA library RB237 used 
for the isolation of UBPl was obtained by cloning a  partial Sau3AI 
digest of S. cereuisiae genomic DNA into the BamHI site of the 
URAS-CEN4-based  vector YCp50 (Rose et al., 1987). 
Ubiquitin-containing Test Proteins-Ub-M-pgal (ubiquitin-Met-& 
galactosidase) (see Fig. lA, V) and  the otherwise identical Ub-P-pgal 
containing proline (instead of methionine) a t  the Ub-pgal junction 
were purified by affinity chromatography of extracts from [35S]me- 
thionine-labeled E. coli (carryingpKKUb-M-pgal or pKKUb-P-pgal)) 
on aminophenylthiopyranogalactoside-Sepharose as described by 
Gonda et al. (1989). Ub-M-DHFR (ubiquitin-Met-mouse dihydrofo- 
late reductase) (Fig. lA, ZV) was prepared as follows: an overnight 
culture (1 ml) of E. coli JMlOl carrying the plasmid pub-M-DHFR 
(Bachmair and Varshavsky, 1989) was diluted into 50 ml of LB 
supplemented with ampicillin at 40 pg/ml, and  the cells were  grown 
with shaking at 37  "C to  an A600 of  -0.9. The culture was chilled on 
ice for 15 min, centrifuged at 3000 X g for 5 min, and washed twice 
with M9 buffer (Ausubel et al., 1989) at  4°C.  The cells were resus- 
pended in M9 buffer supplemented with glucose (0.2%), thiamine (2 
pg/ml), ampicillin (40 pg/ml), 1 mM isopropylthiogalactoside, and 
methionine assay medium (0.0625%) (Difco). After incubation with 
shaking for 1 h at  37 "C, 1 mCi  of Tran~~~S- labe l  (ICN; at least 70% 
of 35S is in L-methionine, with the rest in L-cysteine and related 
compounds) was added, and shaking was continued for 5 min. Unla- 
beled L-methionine was then added to 1 mM, and shaking was 
continued for another 10 min. Cells were harvested, washed twice 
with M9 buffer, and resuspended in 0.5  ml of 25% (w/v) sucrose, 50 
mM Tris-HC1, pH 8.0.  0.1  ml of freshly prepared egg-white lysozyme 
solution (10 mg/ml; Sigma) in 0.25 M Tris-HC1, pH 8.0, was then 
added, and  the mixture was incubated for 5 min at 0 "C,  followed  by 
the addition of 0.1 ml of 0.5 M Na-EDTA, pH 8.0, and further 
incubation at  0 "C for 5 min. The suspension was transferred into a 
centrifuge tube  containing 0.975  ml of 65 mM Na-EDTA, 50 mM Tris- 
HCl (pH 8.0), and protease inhibitors  antipain, chymostatin, leupep- 
tin, pepstatin, and aprotinin, each at 25 pg/ml. 10 p1 of 10% (v/v) 
Triton X-100 was then added and dispersed by pipetting. The lysate 
was centrifuged at 40,000 X g for 30 min. The supernatant, containing 
the 35S-labeled Ub-M-DHFR, was frozen in liquid nitrogen and stored 
at -85  "C. To purify Ub-M-DHFR, a  methothrexate (MTX) affinity 
matrix was prepared as described by Kaufman (1974), using amino- 
hexyl-Sepharose (Sigma). The MTX-Sepharose column (0.5-ml  bed 
volume) was washed with 10 ml of MTX buffer (0.2 M NaCl, 1 mM 
Na-EDTA, 0.2 mM dithiothreitol (DTT), 20  mM Na-HEPES, pH 
7.5). The Ub-M-DHFR-containing 35S supernatant was thawed, clar- 
ified by centrifugation at 12,000 X g for 1 min, and applied to  the 
column, which  was then washed with 50  ml of MTX buffer, 50 ml of 
MTX buffer containing  2 M urea, and  then again with 50  ml  of MTX 
buffer. Ub-M-DHFR was then eluted from the column with folic acid 
buffer (10 mM folic acid, 1 M KCI, 1 mM DTT, 1 mM Na-EDTA, 0.2 
M potassium borate, pH 9.0). The folic acid buffer was applied in 1- 
ml aliquots, and 1-ml fractions were collected. The fractions were 
assayed for 35S; pooled fractions containing the peak of 35S were 
dialyzed for 20 h at 4 "C against two changes of storage buffer (50% 
glycerol, 1 mM MgCI2, 0.1 mM Na-EDTA, 40 mM Na-HEPES, pH 
7.5), and stored at -20 "C. The purified [35S]Ub-M-DHFR was as- 
sayed by SDS-PAGE and fluorography and found to be greater than 
95% pure. Other test proteins such as DHFR-Ub-M-pgal (Fig. L 4 ,  
VI), and  the natural yeast ubiquitin fusions UBI2 (Fig. L4, I), UBI3 
(Fig. lA, II), and UBI4 (polyubiquitin; Fig. lA, III), were expressed 
in E. coli and assayed for deubiquitination with UBPl in mixed E. 
coli extracts as described below. 
Sib Selection Cloning of the UBPl Gene-E.  coli HBlOl cells 
carrying the S. cereuisiue genomic DNA library RB237 (see above) 
were spread on LB plates  containing 100 pg/ml ampicillin (LB/amp) 
to yield -40 colonies per plate. After -16 h at 36"C, the colonies 
were replica-plated onto LB/amp plates; the original plates were 
stored at 4 "C, while their replicas were incubated at  36 "C for 24  h. 
Cells on each of the replica plates were then eluted with 1 ml  of LB/ 
amp by repeated washing over the agar surface until all of the colonies 
were dispersed into  the liquid. The eluates were each diluted with 4 
ml of LB/amp and incubated overnight with shaking at 36 "C. 1.7 ml 
of each overnight culture was chilled on ice and centrifuged at 12,000 
X g for 1 min. The pellet was resuspended by vortexing in 50 p l  of 
25% (w/v) sucrose, 0.25 M Tris-HC1 (pH 8.0). 10 pl of freshly prepared 
egg-white lysozyme solution (10 mg/ml; Sigma) in 0.25 M Tris-HC1 
for 5 min. 0.15 ml of 75 mM Na-EDTA, 0.33 M Tris-HC1 (pH 8.0) 
(pH 8.0)  was added, mixed by light vortexing, and incubated at 0 "C 
was then added, followed by incubation at 0°C for 5 min, with 
occasional stirring. 1 p1 of 10% (v/v) Triton X-100 was then added 
and mixed by pipetting.  Each of the resulting lysates was centrifuged 
at  12,000 X g for 15 min at 4 "C, and  the  supernatants were tested for 
Ub-specific protease activity as described below, using Ub-M-DHFR 
as the test substrate. Upon finding a positive extract, overnight 
cultures were made as described above from each of the -40 individual 
colonies on the plate that yielded the positive extract.  A YCp50-based 
plasmid, named pJT55, was then isolated from a  transformant that 
yielded a positive extract upon the second round of screening. The 
yeast DNA insert of pJT55 was analyzed as described below. 
In Vitro  Assays for Ub-specific Protease Actiuity-An E. coli extract 
(9 pl) prepared as described above was added to 1 p l  of an 35S-labeled 
test protein (Ub-M-DHFR, Ub-M-pgal, or Ub-P-@gal) in storage 
buffer (see above), and incubated at 36°C for 3 h. 5 p1 of 3-fold 
concentrated  SDS-PAGE sample buffer (6% SDS, 33% glycerol, 30 
mM Na-EDTA, 0.3 M DTT, 0.6% bromphenol blue, 0.3 M Tris-HC1, 
pH 6.8)  was then added, followed by heating of the sample at 100 "C 
for  3 min, electrophoresis in  a 6% (for @-galactosidase) or a 12% (for 
DHFR) polyacrylamide-SDS gel, and fluorography. 
Similar tests using the unlabeled natural ubiquitin precursors 
UBI2, UBI3, and UBI4 (see introduction) were carried out as follows. 
5 pl of an  E. coli extract to be tested for Ub-specific protease activity 
was  mixed with 5 pl of an E. coli extract prepared as described above 
from E. coli carrying a plasmid that expressed UBI2,  UBI3, or UBI4 
(Ozkaynak et al., 1987; Finley et al., 1987). The mixture was incubated 
for 1 h at 36"C, followed by SDS-PAGE as described above, and 
immunoblot analysis using a  rabbit polyclonal anti-Ub antibody (a 
gift from Dr. Vincent Chau, Wayne State University, Detroit MI). 
Specifically, after  SDS-PAGE, the gel and PVDF membrane (Milli- 
pore) were equilibrated with transfer buffer (20% methanol, 0.2 M 
glycine, 25 mM Tris), followed by electroblotting of proteins from the 










FIG. 1. Test ubiquitin fusions and UBPl-containing plasmid pJT’7O. In A: I, the yeast UBI1 and UBI2 
gene products (their amino acid sequences are  identical)  are the  natural fusion of ubiquitin to a specific ribosomal 
protein (Finley et al., 1989); 11, the yeast UBI3 protein is the  natural ubiquitin fusion to another ribosomal protein; 
I l l ,  the yeast UBI4 protein is the  natural head-to-tail, spacerless fusion of five ubiquitin moieties (Ozkaynak et 
al., 1987); IV, Ub-M-DHFR is an engineered fusion of yeast ubiquitin to mouse dihydrofolate reductase (DHFR), 
the junctional residue being methionine (M); V, same as  IV  but a fusion to E. coli P-galactosidase; VI, DHFR-Ub- 
M-pgal, same as V but with the ubiquitin moiety bearing at  its amino terminus the mouse DHFR moiety (connected 
to ubiquitin via a Ser-Gly-Gly-Gly linker). Black rectangles indicate the 45-residue sequence from an internal 
region of E. coli lac repressor that is present at  the amino  termini of DHFR and pgal in these engineered test 
proteins  (Bachmair and Varshavsky, 1989). With the exception of pgal, the lengths of rectangles are proportional 
to  the sizes of protein moieties. (See “Experimental Procedures” for details.) In B: pJT70, the plasmid that carries 
the -2.8-kb, UBPl-containing yeast genomic  DNA insert. (See “Experimental Procedures” and text for details.) 
The membrane was washed in ANT buffer (0.15 M NaC1, 0.02% 
NaN,, 50 mM Tris-HC1, pH 8.0), then incubated (at room tempera- 
ture) with rocking in  ANT buffer plus 20% fetal calf serum, followed 
by a 2-h incubation at room temperature with the anti-Ub antibody 
in ANT/fetal calf serum buffer. The membrane was then washed 
several times in ANT buffer plus 0.05% Tween 20.  An alkaline 
phosphatase-linked anti-rabbit second antibody (Promega Biotech) 
in the ANT/Tween buffer was added, followed by a 30-min incubation 
at room temperature, washing of the membrane in ANT/Tween 
buffer, and detection of the bound second antibody using a chromo- 
genic phosphatase  substrate  (Sigma). 
A positive control for a Ub-specific processing protease activity 
was an extract prepared from S. cerevisiae (strain BWG1-7a): cells 
from 1.5 ml of a  stationary  culture grown in  YPD were pelleted by 
centrifugation, washed twice with HzO, and resuspended in 0.15 ml 
of 1% (v/v)  Triton X-100, 1 mM Na-EDTA, 50 mM Na-HEPES  (pH 
7.5), containing  antipain,  chymostatin, leupeptin, pepstatin, and 
aprotinin, each at 25 pg/ml, and (freshly added) 1 mM phenylmeth- 
ylsulfonyl fluoride. 0.3 g of 0.5-mm glass beads was then added, and 
the cells were disrupted by vortexing at 4 “C for 1 min three times, 
with 1-min pauses on ice. The suspension was centrifuged at 12,000 
x g for 5 min, and  the  supernatant was used as a positive control in 
the in vitro deubiquitination assays. 
In  Vivo Assay for Ub-specific Protease Activity-The UBPl pro- 
tease activity with one of the test proteins, DHFR-Ub-M-pgal, in 
which ubiquitin bore an amino-terminal and a carboxyl-terminal 
extension, was assayed using E.  coli that expressed both UBPl  and 
DHFR-Ub-M-pgal. A plasmid (p DHFRUbMPgal) that expressed the 
latter protein in E. coli from the yeast GALlO promoter was con- 
structed by inserting the -0.67-kb BarnHIIHindIII fragment from 
the plasmid pMet-1, which contained the complete mouse DHFR 
coding sequence (Bachmair and Varshavsky, 1989), into the KpnI 
site-containing version of the pUB23 plasmid (Gonda et al., 1989). 
Site-directed mutagenesis using the Muta-Gene kit (Bio-Rad) was 
employed to position the  start codon of the DHFR reading frame 
downstream of the GALlO promoter of pUB23 (Bachmair  et al., 1986) 
and to produce a reading frame that encoded a 4-residue linker 
sequence (Ser-Gly-Gly-Gly) between the carboxyl terminus of DHFR 
and  the amino  terminus of ubiquitin, yielding the plasmid 
pDHFRUbMpga1. 
E. coli JMlOl carrying pDHFRUbMPga1, alone or together with 
the compatible plasmid pJT184 (see below) that expressed UBP1, 
was grown in LB (in the presence of ampicillin at 40 pg/ml and 
chloramphenicol at 35 pg/ml to maintain the plasmids) to  an AGW of 
-0.3. 1 ml  of the culture was centrifuged at 12,000 X g for 1 min. The 
cells were resuspended in 50 p1 of  M9 buffer containing glucose (0.2%) 
and thiamine (2 pg/ml) and incubated at 36 “C for 10 min, followed 
by the addition of 20 pCi of Tran~~~S- labe l  (ICN)  and a  further 2- 
min incubation. Unlabeled L-methionine was then added to a final 
concentration of 1 mM, the cells were incubated for 10 min at 36 “C, 
then centrifuged at 12,000 X g for 30 s, washed once in cold M9 
buffer, and resuspended in 50 p1 of lysis buffer (4% SDS, 125 mM 
Tris-HCI, pH 6.8), followed immediately by heating at 100°C for 4 
min. The sample was then added to 1 ml of immunoprecipitation 
buffer (1% Triton X-100, 0.5% Na-deoxycholate, 0.15 M NaCl, 5 mM 
Na-EDTA, 50 mM Na-HEPES, pH 7.5, plus freshly added 1 mM 
phenylmethylsulfonyl fluoride), centrifuged at 12,000 X g for 10 min 
at 4  “C, and  the upper 0.9 ml of the  supernatant was added to 6 pl of 
a  concentrated hybridoma supernatant containing  a monoclonal an- 
tibody to Pgal (Bachmair et al., 1986). The sample was incubated in 
a microcentrifuge tube for 1 h at 0°C. 10 p1 of protein A-agarose 
(Repligen) was then added; the suspension was incubated with rock- 
ing for 30 min at  4”C,  and centrifuged for 15 s at 12,000 X g. The 
taining 0.1% SDS, dissolved in the SDS-PAGE, sample buffer, and 
pellet was washed three times with immunoprecipitation buffer con- 
electrophoresed in  a 6% polyacrylamide-SDS gel,  followed  by fluoro- 
graphy. 
Plasmid Manipulations and DNA Sequencing-Plasmids were con- 
structed using standard procedures (Ausubel et al., 1989). DNA frag- 
Jolla, CA). The YCp50-based plasmid (named pJT55)  that conferred 
ments were isolated from agarose gels using Geneclean (BiolOl, La 
deubiquitinating activity onto E. coli (see above and “Results”) had a 
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-15-kb yeast genomic DNA insert  (data  not  shown). SphI digestion 
of pJT55 yielded a -10-kb fragment which,  upon subcloning  into  the 
SphI-cut vector  pUC19 (Yanisch-Perron et al.,  1985), conferred  the 
same  deubiquitinating  activity  (plasmid  pJT57). The -10-kb yeast 
DNA insert of pJT57 was cut with SphI and XhoI, yielding  a -5.5- 
kb fragment,  which  was  subcloned into pUC19. The resulting plasmid, 
pJT60, also  conferred deubiquitinating activity onto E. coli (see 
“Results”). 
Since  further  subcloning of the pJT6O insert,  using  its ingle KpnI 
site, did not yield a deubiquitinating  activity-conferring  fragment,  the 
two  fragments of the  KpnI-cut, -5.5-kb insert of pJT6O were sub- 
cloned into M13mp18 and M13mp19 (Yanisch-Perron  et al., 1985), 
and  sets of nested  deletions were generated  using  the 3’ exonuclease 
activity of T4 DNA  polymerase (Dale  et al., 1985). Single-stranded 
M13  DNA was sequenced using  the  Sequenase  kit (U. S. Biochemical 
Corp.) under conditions recommended by the manufacturer. The 
internal KpnI site in pJT6O was found to reside within a 2427-bp 
open reading frame  (ORF), which  was  sequenced on  both  strands. 
The sequence information was then used to subclone further  the 
pJT6O insert. Following digestion with AccI, the 5’ overhangs of the 
resultant -2.8-kb fragment were filled in with  Klenow  PolI, followed 
by ligation of SalI linkers. The  fragment was then digested with  SalI 
and  RamHI, purified by agarose gel electrophoresis, and subcloned 
into  SalIIBamHI-cut pUC19. The  resultant plasmid, JT70,  conferred 
the  deubiquitinating  activity  onto E. coli as efficiently as the  initial 
pJT57 plasmid (data  not  shown),  indicating  that  the  corresponding 
Ub-specific protease, named UBPl,  was  encoded by the 2427-bp ORF 
within  the -2.8-kb insert of pJT70 (Fig. 1B). 
For  experiments that  involved the  simultaneous  presence of two 
distinct  plasmids  in E. coli, the UBPl -containing  insert of pJT70 was 
excised  with SalI  and  BamHI,  and subcloned into  the  SalIIBamHI- 
cut vector pACYC184 (New England Biolabs), yielding pJT184. 
pACYC184 bears the P15A origin of replication, which makes i t  
compatible  with  pMBl(ColE1)-based E. coli vectors  such as pUCl9 
and pBR322 (Sambrook et al., 1989). 
The nucleotide and  (predicted)  amino  acid sequences of the UBPl 
gene and  protein were compared to sequences in  the  GenBank (ver- 
sion 66.0), EMBL (version 23.0), and  GENPEPT  (a  translated ver- 
sion of GenBank)  databases,  using  the  FastA  algorithm  (Pearson  and 
Lipman, 1988). 
Construction of a Null ubpI Mutant-A ubpl null allele  was made 
in uitro by replacing 81% of the UBPl coding region with a fragment 
carrying  the  yeast URA3 gene. First,  the  entire -15-kb yeast  DNA 
insert of pJT57 was  subcloned into  pUC9  to yield pJT9, which  was 
then digested with ClaI and KpnI. The resultant -2-kb fragment, 
encompassing 81% of the UBPl ORF, was  replaced with  the URA3- 
containing -1.1-kb fragment of pRBU1, yielding pJT9K.  The  plasmid 
pRBU1, kindly provided by Dr. R. T. Baker, was constructed by 
isolating the -1.1-kb HindIIIISmaI  fragment from  YEp24 (Botstein 
et al., 1979),  filling in  the Hind111 site  using Klenow  PolI, and ligating 
the  blunt-ended  fragment  into  SmaI-cut pUC19. 
The -7.7-kb linear  DNA from SalI-cut  pJT9K  that included the 
deletion/disruption ubpl-AI allele was  used to  transform  both haploid 
(BBY45) and diploid (DF5) ura3 yeast  strains.  Southern hybridiza- 
tion analysis of haploid and diploid Ura’ transformants (with the 
latter expected to be heterozygous at the UBPl locus)  confirmed the 
predicted  structure of the ubpl-A allele by showing the presence of 
restriction endonuclease sites diagnostic of the  transplacement  (data 
not  shown)  (Rothstein, 1983). 
RESULTS 
The UBPl Gene-The previously cloned Ub-specific proc- 
essing  protease of S. cereuisiae, YUH1,  cleaves ubiquitin from 
relatively short  carboxyl-terminal  extensions of ubiquitin  but 
is virtually  inactive with larger ubiquitin  fusions  such as Ub- 
Pgal (Miller et al., 1989).2 The efficient deubiquitination of 
the  latter fusion in  yeast cells and cell-free extracts  (Bachmair 
et al., 1986; Bachmair  and Varshavsky, 1989; see also below), 
as well as  the  properties of null yuhl mutants (Miller et al., 
specific processing proteases. To  clone the corresponding 
genes, we took  advantage of the  fact  that  bacteria  such as E. 
coli lack  eukaryotic ubiquitin  and Ub-specific enzymes (Finley 
1080) indicatcd that S. ~-cr.suidue cullLains a h1lily of Ub- 
J. Tobias  and A. Varshavsky, unpublished results. 
et dl., 1988). Specifically, the sib selection strategy (Mc- 
Cormick, 1987; Lederberg, 1989) was used to isolate a gene 
from a S. cereuisiae genomic DNA library  that could confer 
Ub-specific protease  activity  onto E. coli. To  be  clonable by 
this  strategy, a yeast gene must have a promoter  that func- 
tions  in E. coli (a minority of yeast  promoters  are  able  to  do 
so), must lack introns  in coding region (most  yeast genes  lack 
introns), and must encode a protein that functions as a 
monomer or a homooligomer and that is active in E. coli 
extracts. 
E. coli transformed with a S. cereuisiue genomic DNA 
library (see “Experimental  Procedures”) were spread  on  plates 
to yield -40 individual  colonies per  plate. Overnight cultures 
were then seeded  by pooled inoculums from a replica of each 
plate. Extracts from these  cultures were tested for their  ability 
to  deubiquitinate  UB-M-DHFR (Fig. LA IV) ,  and  one of the 
extracts showed the  activity (Fig. 2). Overnight cultures were 
then  made  as above  from  each of the -40 individual colonies 
on  the  plate  that yielded the positive extract.  Extracts from 
these cultures were tested for the  deubiquitinating activity 
with Ub-Met-DHFR,  and a single positive extract was ob- 
tained. 
A plasmid (named pJT55) was then isolated from the 
individual E. coli transformant  that yielded the positive ex- 
tract.  Its -15-kb yeast DNA insert was  subcloned to yield a 
-5.5-kb fragment  (the  plasmid pJT6O) that was  indistinguish- 
able from the original insert  in conferring the  deubiquitinating 
activity  onto E. coli (see  “Experimental  Procedures”).  Since 
further subcloning, using  the  KpnI  site  in  the middle of the 
5.5-kb insert of pJT60, did not produce activity-conferring 
fragments,  the  insert was  sequenced in  both  directions from 
the KpnI site, which was found to reside within an  open 
reading  frame (ORF). This sequence information was  used to 
subclone further the insert in pJT60, yielding pJT70 (Fig. 
lB), whose -2.8-kb, activity-conferring insert  contained  the 
2427-bp ORF (Fig. 3) encoding an acidic (calculated PI of 
4.63), 809-residue (-93 kDa)  protein, which  was named UBPl  
(for ubiquitin-specific protease).  This  designation conforms 
to the  existing  convention for naming genes encoding com- 
ponents of the  ubiquitin system in S. cereuisiae ( UBIl-UBI4 
for the  ubiquitin genes  (Ozkaynak et al., 1984, 1987; Finley et 
al., 1987, 1988); UBC1-UBC7 for the genes encoding Ub- 
conjugating enzymes (Jentsch et al., 1987, 1990); UBRl for 
the gene encoding  the recognition component of the  N-end 
rule  pathway,  one  Ub-dependent proteolytic pathway  (Bartel 
et al., 1990)). 
The  position of the start (ATG) codon in  UBPl was in- 
ferred so as  to yield the longest ORF. No  ATGs occur in  any 
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FIG. 2. Cloning of the UBPl gene. A sib selection strategy was 
used to isolate  a  gene  from  a S. cereuisiae genomic DNA  library that 
could  confer Ub-specific protease activity onto E. colicells that  carried 
such a gene. Lane a, partial in uitro deubiquitination of the ”S-labeled 
Ub-M-DHFR by an  extract  from  the (pooled) 40 individual E. coli 
“Experimental  Procedures”). Lune b, same  as lane a but  an  extract 
from  a pool that  lacked the  deubiquitinating activity. Lane c, purified, 
“S-labeled Ub-M-DHFR  (control). Lane d, same as lane c but  after 
incubation  with a whole cell yeast  extract (see “Experimental  Pro- 
cedures”). Arrowhead denotes an unrelated cleavage product of Ub- 
M-DHFR  that formed in  the  control  (UBP1-lacking) E. coli extract. 
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FIG. 3. Nucleotide sequence of the 1159 
UBPl gene and deduced amino acid 1249 
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initiator ATG until position -200 (Fig. 3). The codon adap- 
tation index (calculated according to Sharp  and Li, 1987) for 
UBPl is 0.19, characteristic of weakly expressed yeast genes. 
Computer-aided comparisons of the UBPl nucleotide se- 
quence and of the predicted amino acid sequence of UBPl  to 
sequence databases (see "Experimental Procedures") revealed 
no significant similarities to sequenced genes or gene prod- 
ucts. In particular, UBPl lacks sequence similarities to pro- 
teins that are either known or expected to interact with 
ubiquitin, including several yeast UB-conjugating (UBC) en- 
zymes (Jentsch et al., 1990), UBCs from other organisms 
(Sullivan and Vierstra, 1989; Reynolds et al., 1990; Schneider 
et al., 1990), and,  in  addition, more surprisingly, the  YUHl 
Ub-specific processing protease (also called ubiquitin hydro- 
lase) (Miller et al., 1989) and  its mammalian homologs (Wilk- 
inson  et al., 1989). 
Substrate Specificity of the UBPl Protease-Extracts from 
E. coli carrying either the pUC19 vector alone or the pUC19- 
based pJT7O plasmid that expressed the yeast UBPl protease 
were added to a variety of Ub-containing test proteins (see 
"Experimental Procedures"). The reaction products were frac- 
tionated by SDS-PAGE, followed either by fluorography (for 
the purified 3sS-labeled test proteins) (Fig. 4, A-C) or by 
immunoblotting with anti-Ub antibodies (Fig. 40). 
The  UBPl protease was ATP-independent  (data  not 
shown),  and cleaved ubiquitin from the tested carboxyl-ter- 
minal extensions of ubiquitin, such as Ub-X-pgal or UB-X- 
DHFR, where X is any of the 20 amino acid residues except 
proline (Figs. 1, 4 A ,  and  data not shown). When the residue 
X was proline, the UBP1-mediated deubiquitination was 
strongly inhibited (Fig. 4A). This  pattern of substrate speci- 
ficity was indistinguishable from that observed with S. cere- 
uisiae using the same test  proteins  either in uiuo (Bachmair 
et al., 1986; Bachmair and Varshavsky, 1989) or in whole  cell 
extracts (Fig. 1 and  data  not shown). 
UBPl could also deubiquitinate  natural ubiquitin fusions 
such  as UBI1-UBI3, which are precursors of both ubiquitin 
and specific ribosomal proteins (see Introduction). Deubiqui- 
tination of UBI2 and  UBI3 by the  UBPl protease (the amino 
acid sequence of UBI1 is identical to  that of UBI2 (Ozkaynak 
et al., 1987)) was demonstrated by mixing extracts of E. coli 
that either contained or lacked UBPl with E. coli extracts 
containing UBI2 or UBI3. Deubiquitination of the  test sub- 
strates was monitored by SDS-PAGE and immunoblotting 
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FIG. 4. Substrate  specificity of the UBPl protease. A, puri- 
fied, :”S-labeled Ub-M-@gal (Fig. IA, V )  and Ub-P-@gal (the latter 
containing proline instead of methionine at   the Ub-@gal junction) 
were incubated with UBPI-containing  or  UBP1-lacking E. coli ex- 
tracts,  or with  a S. cereuisiae extract,  as indicated on  top of the lanes, 
followed by electrophoretic  analysis of pgal. The  bands of Ub-X-pgal 
and X-pgal are indicated on  the left. B, kinetics of in oitro  deubiqui- 
tination of the ‘”S-labeled Ub-M-@gal (Fig. lA, V )  by extracts  from 
S. cereoisiae carrying either the wild-type or disruption/deletion 
(ubpl-AI) alleles of the yeast UBP1 gene. After incubations for 
specified periods of time, p-galactosidase was analyzed by SDS- 
PAGE. C, in oioo deubiquitination of DHFR-Ub-M-pgal (Fig. lA, V I )  
in [:%]methionine-labeled E. coli expressing the  yeast UBP I gene. 
Lane a, E. coli expressing both  UBPl  and Ub-M-Bgal (Fig. L4, V )  
were  labeled  with  [“‘Slmethionine, followed by extraction,  immuno- 
precipitation,  and  electrophoretic  analysis of &galactosidase. Lane b, 
same as lane a but with E. coli lacking the yeast UBPI gene and 
expressing  DHFR-Ub-M-Bgal. Lane c, same  as  lane b but  with E. coli 
expressing both  UBPl  and DHFR-Ub-M-@gal.  Arrowheads indicate 
the species which are  either  partial  (apparently  in oioo) degradation 
products of DHFR-Ub-M-@gal,  with cleavages in  its  DHFR moiety, 
or the primary translation products due to initiations within the 
DHFR-coding region of the  ORF for DHFR-Ub-M-@gal  (all of these 
species were converted into M-cgal in the presence of the UBPl 
protease; lane c). D, in vitro deubiquitination assays with natural 
ubiquitin fusions. Lane a, an  extract  from E. coli expressing UBI2 
(Fig. lA, I )  was mixed with an  extract from E. coli lacking  the  yeast 
UBPl protease, followed by an incubation,  SDS-PAGE,  and  detection 
of ubiquitin-containing species using  immunoblot  analysis with an 
anti-Ub  antibody  (see  “Experimental  Procedures”).  Lane b, same as 
lane a but with the second extract being  from  yeast. Lane c, same  as 
lane b but with the second extract being from E. coli expressing 
UBPI. Lane d, same  as lane a but with the  first  extract being  from 
E. coli expressing UBI3 (Fig. l A ,  I I ) .  Lane e, same  as  lane d but with 
the second extract being  from yeast.  Lane f ,  same  as  lane e but with 
the second extract being from E. coli expressing UBPl.  Note  that 
UBPl cleaves ubiquitin  from both  UBI3  and  its  partial  degradation 
products  seen  in c. Lane g, same  as  lane a, but with the  first  extract 
being from E. coli expressing UBI4 (Fig. l A ,  I I I ) .  Lane h, same as 
lane g but with the second extract being  from  yeast. Lane i, same  as 
lane h but with the second extract being from E. coli expressing 
UBPI. Partially deubiquitinated derivatives of UBI4 (which is de- 
noted  as UB5) are indicated on  the right. (See  “Experimental  Proce- 
dures” for details.) 
with  anti-Ub  antibodies (Fig. 4 0 ) .  
Polyubiquitin,  a naturally occurring  spacerless, head-to-tail 
fusion of several ubiquitin moieties (Ozkaynak et al., 1984, 
is  the only linear  ubiquitin fusion that was not cleaved in  a 
UBP1-containing E. coli extract; however, the same yeast 
polyubiquitin  (encoded by UBZ4 (Ozkaynak et al., 1987)) was 
converted  into  mature  ubiquitin by a whole-cell yeast  extract 
(Fig. 4 0 ) ,  indicating  that S. cereukiue contains Ub-specific 
1987; Dworlrin Root1 ct al., 1084; Schlasillgar a ~ d  D u d ,  1987), 
2.5 kb 
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FIG. 5. Wild-type and null alleles of the UBPl gene. Re- 
placement of the wild-type UBP I allele with the  deletion/disruption 
ubpl-A1::URAd allele generates a new arrangement of EcoRI sites 
detectable by Southern hybridization analysis of Ura’ S. cereuisiae 
transformants using the indicated DNA probe. (See  “Experimental 
Procedures” for details.) 
proteases whose in vitro substrate specificity is  different from 
those of UBPl  and YUH1. More recent  data3 indicate that 
UBP1, while inactive with polyubiquitin in vitro (in E. coli 
extracts), was able to cleave it in uiuo, when UBPl and 
polyubiquitin were expressed together  in E. coli (see  “Discus- 
sion’’). 
The  UBPl protease also  did not cleave in uitro a branched 
ubiquitin conjugate such as the multiubiquitin chain (see 
Introduction). Specifically, no cleavage of the  in vitro-formed, 
P-galactosidase-attached multiubiquitin chain (Chau et al., 
1989) by the  UBPl protease was  observed  when the  UBP1- 
containing E. coli extract was  added to %-labeled, multiubi- 
quitinated @-galactosidase (data  not shown). 
The  UBPl protease  deubiquitinated carboxyl-terminal 
ubiquitin  fusions even if the  ubiquitin moiety  bore  in  addition 
an  amino-terminal extension. This was shown by expressing 
a fusion protein DHFR-Ub-M-pgal (Fig. lA, VI) in E. coli 
either by itself or together with UBPl (see “Experimental 
Procedures”). The cells were labeled with [”S]methionine, 
extracts were prepared,  and  immunoprecipitated with  a  mono- 
clonal  antibody to p-galactosidase (Fig. 4C). When E. coli did 
not  carry a UBPl -expressing  plasmid,  several protein species, 
including the one whose apparent molecular mass equaled 
that of DHFR-Ub-M-@gal, were precipitated by the  anti-pgal 
antibody (Fig. 4C, lane b) .  However, in E. coli that expressed 
both  DHFR-Ub-M-pgal  and UBP1, all of these P-galactosid- 
ase species were converted  to  the  one  that comigrated  with 
M-pgal (Fig. 4C, lane c). Note  that smaller p-galactosidase- 
containing  proteins (Fig. 4C, arrowheads) in E. coli lacking 
UBPl  and expressing  DHFR-Ub-M-@gal were due  either  to 
alternative translation start sites or proteolytic cleavages 
within  the  DHFR moiety of the fusion protein,  inasmuch as 
all of these species were converted by UBPl  into M-pgal (Fig. 
4C, lune c). 
Null  ubpl Mutants-Haploid S. cereuiside strains in which 
81% of the  UBPl  ORF was deleted and replaced with  the 
URA3 gene were constructed  as described under  “Experimen- 
tal Procedures” (Fig. 5). These  ubpl-A1  strains grew normally 
and lacked obvious phenotypic  abnormalities  (data  not 
shown).  In  addition,  extracts from ubrl-A1 cells were indis- 
tinguishable from wild-type extracts  in  their  ability  to deubi- 
quitinate  ubiquitin fusions such  as  Ub-M-DHFR  and Ub-M- 
pgal (Fig. 4B and  data  not  shown),  indicating  that  the family 
of Ub-specific proteases  in  yeast  is  not limited to  UBPl  and 
YUH1. 
DISCUSSION 
We have cloned a gene for UBP1, a new member of the 
family of Ub-specific processing proteases in S. cereuisiae. 
’ R. Baker  and A. Varshavsky, manuscript in preparation. 
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The  UBPl protease is an 809-residue protein that has no 
significant sequence similarities  to  known  proteins, including 
the only other previously  cloned yeast Ub-specific processing 
protease,  the 236-residue YUHl (Miller et al., 1989). While 
the  YUHl protease  is  virtually  inactive  against relatively  long 
ubiquitin  fusions  such  as Ub-@gal (Miller  et al., 1989),2  the 
UBPl  protease of the  present work cleaves at the carboxyl 
terminus of ubiquitin  in  natural  and  engineered fusion pro- 
teins irrespective of their size or the  presence of an  amino- 
terminal  ubiquitin  extension (see “Results”).  The  latter  prop- 
erty of UBPl  makes  it possible to  express  ubiquitin  fusions 
t o  proteins of interest  as  “triple”  fusions, whose amino-ter- 
minal ubiquitin extension, e.g. the biotin-binding protein 
streptavidin, could be used  to purify the fusion by affinity 
chromatography  (from  bacteria  such  as E. coli that lack Ub- 
specific proteases) before the  UBP1-mediated  deubiquitina- 
tion  step. 
Among the ubiquitin fusions tested in the present work, 
polyubiquitin  is  the only linear fusion that  is  not a substrate 
for the UBPl protease in vitro (see “Results”). Since the 
amino-terminal region of ubiquitin, and in particular its 
amino-terminal  methionine residue, is  an  integral  part of the 
compact  ubiquitin globule (Vijay-Kumar et al., 1987; Wilkin- 
son,  1988),  the cleavable Gly-Met  bond between  two adjacent 
ubiquitin moieties  in polyubiquitin may be  sterically shielded 
t o  a greater  extent  than  are analogous Gly-X  bonds  in ubiqui- 
tin fusions that lack the  Ub-Ub  motif.  It  has  recently  been 
found  that  UBP1, while unable  to  deubiquitinate polyubiqui- 
tin  in vitro, can  do so in vivo, when coexpressed with polyu- 
biquitin  in E. A  likely explanation  is  that  he  UBP1- 
mediated  deubiquitination of polyubiquitin  in vivo is  cotrans- 
lational or, more generally, occurs before the folding of the 
newly formed, multidomain  polyubiquitin  protein  is complete. 
UBPl  also did not cleave in vitro a branched ubiquitin 
conjugate  such as the  multiubiquitin  chain (see Introduction 
and  “Results”).  It  remains  to  be  determined  whether  UBPl 
fails  to cleave the  multiubiquitin  chain  in vivo as well. 
Although UBPl  is  able to  cleave all of the  tested  natural 
and engineered ubiquitin  fusions at  least  in vivo (see above), 
and  although  the processing of natural  ubiquitin  precursors 
is  essential for cell viability (Finley  et al., 1989), UBPl is a 
nonessential gene: the  null ubpl mutant  is viable, grows at  a 
wild-type rate,  and is otherwise phenotypically normal (see 
“Results”). Moreover, the double ubpl yuhl mutant, which 
lacks  both  the  UBPl  and  YUHl  proteases,  is  also  phenotyp- 
ically normal,  and  retains  the  ability  to  deubiquitinate  both 
linear  and  branched  Ub-protein conjugates.3 The  multiplicity 
of functionally overlapping  Ub-specific  processing proteases 
in S. cerevisiae accounts,  in  hindsight, for the  failure of our 
earlier efforts to clone the genes for these proteases using 
yeast-based genetic  screens. While  the  strategy of sib selection 
and  functional  cloning in E. coli that yielded the UBPl gene 
bypassed the problem of gene multiplicity, it was initially 
viewed as a strategy unlikely to  succeed  for other  reasons (see 
“Results”). More recent work: using another E. coli-based 
genetic  screen,  has yielded two more S. cerevisiae genes for 
Ub-specific processing proteases, named UBP2 and UBP3. 
Thus,  the  yeast UBP gene family contains at least  four genes, 
including YUHI; a variety of evidence indicates  that  other 
eukaryotes have at  least  as  many  (Rose, 1988; Wilkinson et 
al., 1989; Jonnalagadda  et al., 1989). The  continuing genetic 
and biochemical analyses of the single and  multiple  null ubp 
mutants  should allow more precise definitions of the  appar- 
ently overlapping functions of these  proteases. 
Prior  to  the cloning of YUHl and UBPl, the  presence of 
UB-specific processing proteases in S. cerevisiae and other 
eukaryotes was inferred  from  the existence of polyubiquitin 
genes (Ozkaynak et al., 1984,1987; Dworkin-Rastl  et a1.,1984), 
and from the  demonstration  that  engineered  ubiquitin fusions 
such  as  Ub-X-pgals were precisely deubiquitinated  in vivo or 
in cell-free extracts  (Bachmair  et al., 1986; Gonda  et al., 1989). 
Another  finding,  that  Ub-X-@gals were deubiquitinated  irre- 
spective of the  identity of a  residue X at  the Ub-@gal junction, 
led to  the discovery of the  N-end rule,  which relates  the in 
vivo half-life of a protein  to  the  identity of its  amino-terminal 
residue (Bachmair et a1.,1986). Distinct  versions of the  N-end 
rule have since been shown to operate in all eukaryotes 
examined, from yeast to mammals (Bachmair et al., 1986; 
Varshavsky et al., 1988; Reiss et al., 1988; Bachmair and 
Varshavsky, 1989; Gonda et al., 1989; Johnson et al., 1990; 
Bartel et al., 1990). However, since  ubiquitin  and Ub-specific 
enzymes are absent from bacteria (Finley et al., 1988), the 
ubiquitin fusion technique could not be used to determine 
whether  the  N-end rule operates  in  prokaryotes  as well. The 
isolation of UBPl has allowed us to  bypass  this difficulty, as 
E. coli transformed  with a UBPl -expressing plasmid  acquires 
the  ability  to  deubiquitinate  Ub-X-pgals irrespective of the 
identity of the  junctional residue X ,  proline being the single 
exception. Measurements of the in vivo half-lives of the 
resultant  X-@gals  in E. coli have  shown that a distinct version 
of the  N-end  rule  operates  in  bacteria  as well.4 
Availability of the UBPl gene and the purified UBPl  
protease will increase  the  versatility of the  ubiquitin  fusion- 
based technique for the in vivo or in vitro generation of 
proteins (including short polypeptides) that bear predeter- 
mined residues at their  amino  termini, a method  with  appli- 
cations  in  both basic research  (Baker  and Varshavsky, 1991; 
Bartel  et al., 1990; Johnson et al., 1990; Townsend  et al., 1988) 
and biotechnology (Lu  et al., 1990; Butt et al., 1989; Sabin  et 
al., 1989; Ecker  et al., 1989; Yo0 et al., 1989; Mak  et al., 1989). 
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